The THINC-integrated tool (THINC-it) screening assessment for cognitive dysfunction: Validation in patients with major depressive disorder

Journal of Clinical Psychiatry

Volumn 78, Issue 7, 2017, Pages 873-881

  McIntyre, Roger S ^a,b,c,d   Best, Michael W ^e   Bowie, Christopher R ^e,f   Carmona, Nicole E ^a   Cha, Danielle S ^a,g   Lee, Yena ^a,d   Subramaniapillai, Mehala ^a   Mansur, Rodrigo B ^a   Barry, Harry ^h   Baune, Bernhard T ⁱ   Culpepper, Larry ^j   Fossati, Philippe ^k   Greer, Tracy L ^l   Harmer, Catherine ^m   Klag, Esther ⁿ   Lam, Raymond W ^o   Wittchen, Hans Ulrich ^p   Harrison, John ^q,r,s  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b BRAIN AND COGNITION DISCOVERY FOUNDATION   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e QUEEN S UNIVERSITY   (Canada)

^f CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h Stoneylane Clinic Drogheda   (Ireland)

ⁱ UNIVERSITY OF ADELAIDE   (Australia)

^j BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k SORBONNE UNIVERSITÉ   (France)

^l UNIVERSITY OF TEXAS AT DALLAS   (United States)

^m WARNEFORD HOSPITAL   (United Kingdom)

ⁿ Private Practice   (United Kingdom)

^o UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^p DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^q VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^r METIS COGNITION LTD   (United Kingdom)

^s KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOMATION; CHOICE REACTION TIME IDENTIFICATION TASK; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIGIT SYMBOL SUBSTITUTION TEST; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH; ONE-BACK TEST; PATIENT CARE; PATIENT SATISFACTION; PERCEIVED DEFICITS QUESTIONNAIRE FOR DEPRESSION-5-ITEM; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUALITATIVE ANALYSIS; QUESTIONNAIRE; RATING SCALE; RECURRENT DISEASE; RELIABILITY; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE; THINC-INTEGRATED TOOL; TRAIL MAKING TEST-PART B; VALIDATION STUDY; ADOLESCENT; COGNITION DISORDERS; COMPUTER ASSISTED DIAGNOSIS; DEPRESSIVE DISORDER, MAJOR; MASS SCREENING; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; PSYCHOMETRY; REFERENCE VALUE; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; RECURRENCE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 85028304450     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.16m11329     Document Type: Article

References (47)

1. Wisniewski SR, Rush AJ, Nierenberg AA, et al. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR∗D report. Am J Psychiatry. 2009;166(5):599-607.
2. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.
3. Shilyansky C, Williams LM, Gyurak A, et al. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. Lancet Psychiatry. 2016;3(5):425-435.
4. McIntyre RS, Soczynska JZ, Woldeyohannes HO, et al. The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project. Compr Psychiatry. 2015;56:279-282.
5. Brewster GS, Peterson L, Roker R, et al. Depressive symptoms, cognition, and everyday function among community-residing older adults. J Aging Health. 2017;29(3):367-388.
6. Graziane JA, Beer JC, Snitz BE, et al. Dual trajectories of depression and cognition: a longitudinal population-based study. Am J Geriatr Psychiatry. 2016;24(5):364-373.
7. Jaeger J, Berns S, Uzelac S, et al. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res. 2006;145(1):39-48.
8. Baune BT, Miller R, McAfoose J, et al. The role of cognitive impairment in general functioning in major depression. Psychiatry Res. 2010;176(2-3):183-189.
9. Evans VC, Iverson GL, Yatham LN, et al. The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review. J Clin Psychiatry. 2014;75(12):1359-1370.
10. Greer TL, Kurian BT, Trivedi MH. Defining and measuring functional recovery from depression. CNS Drugs. 2010;24(4):267-284.
11. Katon WJ, Lin EHB, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611-2620.
12. Wykes T, Haro JM, Belli SR, et al; ROAMER Consortium. Mental health research priorities for Europe. Lancet Psychiatry. 2015;2(11):1036-1042.
13. Rush AJ. Isn't it about time to employ measurement-based care in practice? Am J Psychiatry. 2015;172(10):934-936.
14. Yeung AS, Jing Y, Brenneman SK, et al. Clinical Outcomes in Measurement-based Treatment (Comet): a trial of depression monitoring and feedback to primary care physicians. Depress Anxiety. 2012;29(10):865-873.
15. Guo T, Xiang Y-T, Xiao L, et al. Measurementbased care versus standard care for major depression: a randomized controlled trial with blind raters. Am J Psychiatry. 2015;172(10):1004-1013.
16. McIntyre RS, Lee Y, Mansur RB. Treating to target in major depressive disorder: response to remission to functional recovery. CNS Spectr. 2015;20(suppl 1):20-30, quiz 31
17. Harrison JE, Lam RW, Baune BT, et al. Selection of cognitive tests for trials of therapeutic agents. Lancet Psychiatry. 2016;3(6):499.
18. Woo YS, Rosenblat JD, Kakar R, et al. Cognitive deficits as a mediator of poor occupational function in remitted major depressive disorder patients. Clin Psychopharmacol Neurosci. 2016;14(1):1-16.
19. McIntyre RS, Lee Y. Cognition in major depressive disorder: a Systemically Important Functional Index (SIFI). Curr Opin Psychiatry. 2016;29(1):48-55.
20. Robbins TW, James M, Owen AM, et al. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia. 1994;5(5):266-281.
21. McIntyre RS, Cha DS, Soczynska JK, et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety. 2013;30(6):515-527.
22. Culpepper L. Impact of untreated major depressive disorder on cognition and daily function. J Clin Psychiatry. 2015;76(7):e901.
23. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8(7):271.
24. Joy S, Kaplan E, Fein D. Speed and memory in the WAIS-III Digit Symbol-coding subtest across the adult lifespan. Arch Clin Neuropsychol. 2004;19(6):759-767.
25. Marquand AF, Mourão-Miranda J, Brammer MJ, et al. Neuroanatomy of verbal working memory as a diagnostic biomarker for depression. Neuroreport. 2008;19(15):1507-1511.
26. Bruder GE, Alvarenga JE, Alschuler D, et al. Neurocognitive predictors of antidepressant clinical response. J Affect Disord. 2014;166:108-114.
27. Kane MJ, Conway ARA, Miura TK, et al. Working memory, attention control, and the N-back task: a question of construct validity. J Exp Psychol Learn Mem Cogn. 2007;33(3):615-622.
28. Trueman RC, Brooks SP, Dunnett SB. Choice reaction time and learning. In: Seel NM, ed. Encyclopedia of the Sciences of Learning. New York NY: Springer US; 2012:534-537.
29. Lam RW, Saragoussi D, Danchenko N, et al. QL4: psychometric validation of Perceived Deficits Questionnaire-Depression (PDQ-D) in patients with major depressive disorder (MDD). Value Health. 2013;16(7):A330.
30. McIntyre RS. Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities. Cambridge, UK: Cambridge University Press; 2016.
31. Edman G, Schalling D, Levander SE. Impulsivity and speed and errors in a reaction time task: a contribution to the construct validity of the concept of impulsivity. Acta Psychol (Amst). 1983;53(1):1-8.
32. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
33. Müller MJ, Szegedi A, Wetzel H, et al. Moderate and severe depression: gradations for the Montgomery-Asberg Depression Rating Scale. J Affect Disord. 2000;60(2):137-140.
34. Bright P, Jaldow E, Kopelman MD. The National Adult Reading Test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables. J Int Neuropsychol Soc. 2002;8(6):847-854.
35. Rock PL, Roiser JP, Riedel WJ, et al. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44(10):2029-2040.
36. Phillips WJ, Hine DW, Thorsteinsson EB. Implicit cognition and depression: a metaanalysis. Clin Psychol Rev. 2010;30(6):691-709.
37. Gualtieri CT, Johnson LG. Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs. Arch Clin Neuropsychol. 2006;21(7):623-643.
38. Damschroder L, Hall C, Gillon L, et al. The Consolidated Framework for Implementation Research (CFIR): progress to date, tools and resources, and plans for the future. Implement Sci. 2015;10(1):A12.
39. McKnight PE, Kashdan TB. The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research. Clin Psychol Rev. 2009;29(3):243-259.
40. Snyder HR. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull. 2013;139(1):81-132.
41. Thomas Gualtieri C. Computerized neurocognitive testing and its potential for modern psychiatry. Psychiatry (Edgmont). 2004;1(2):29-36.
42. Farrin L, Hull L, Unwin C, et al. Effects of depressed mood on objective and subjective measures of attention. J Neuropsychiatry Clin Neurosci. 2003;15(1):98-104.
43. Lahr D, Beblo T, Hartje W. Cognitive performance and subjective complaints before and after remission of major depression. Cogn Neuropsychiatry. 2007;12(1):25-45.
44. Lehrner J, Moser D, Klug S, et al. Subjective memory complaints, depressive symptoms and cognition in patients attending a memory outpatient clinic. Int Psychogeriatr. 2014;26(3):463-473.
45. Theunissen EL, Street D, Højer AM, et al. A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition. Clin Pharmacol Ther. 2013;93(6):493-501.
46. McIntyre RS, Lophaven S, Olsen CK. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol. 2014;17(10):1557-1567.
47. Papakostas GI. Antidepressants and their effect on cognition in major depressive disorder. J Clin Psychiatry. 2015;76(8):e1046.